The effectiveness of vaccines in women may be influenced significantly by the timing of their menstrual cycle. While the trending concept of #cyclesyncing promotes dietary and lifestyle changes based on menstrual phases, robust research is lacking. Nonetheless, increasing evidence indicates that hormonal fluctuations throughout the cycle can play a crucial role in influencing a woman’s immune response and may affect susceptibility to infections post-vaccination, particularly for the COVID-19 vaccine.

"Historically, the menstrual cycle has been overlooked in health research," states Poppy Cooper from the London School of Hygiene and Tropical Medicine. "This initiative reflects a paradigm shift, acknowledging that the menstrual cycle impacts health beyond just reproductive aspects."

Following the rollout of the COVID-19 vaccine in 2021, anecdotal reports noted changes in women’s menstrual cycles, including heavier and earlier periods. A later study concluded that while these changes were observed, they were generally minor and temporary.

Cooper and her research team have since explored how menstrual cycles may affect vaccine efficacy. By analyzing data from 1,474 women utilizing the menstrual tracking app, Clue, in 2021, who reported their vaccination outcomes through an in-app survey, they uncovered key insights.

Out of the participants, many experienced COVID-19 breakthrough infections, primarily among those who received either the Pfizer or Moderna vaccines. Notably, infections occurred 35 days earlier in women vaccinated during the luteal phase (characterized by high progesterone and pre-implantation of eggs) compared to those vaccinated during the follicular phase (marked by high estrogen and maturation of egg follicles).

This variation might be linked to how sex hormones affect immune cell responses. A 2022 meta-analysis noted a decline in immune-related proteins like antibodies during the luteal phase. "Progesterone prepares the body for potential pregnancy, often by suppressing active immune responses, which isn’t ideal when trying to optimize reaction to a vaccine," explains Dr. Julia Craggs, a women’s health specialist.

Despite its limitations—such as a relatively small number of confirmed coronavirus cases and not accounting for the menstrual cycle’s menstrual and ovulatory stages—the study offers a fresh perspective. It encourages further exploration of how sex hormones may influence women’s health outcomes. "This research recognizes menstrual cycles as a significant factor rather than merely a variable to control for," says Craggs. "Addressing this may uncover vital factors affecting how women respond to healthcare interventions." Recent findings also indicate that estrogen fluctuations can alter drug absorption in women.

Professor Cooper stresses the continuing importance of vaccinations in disease prevention, regardless of menstrual cycle timing. However, he advocates for greater consideration of these factors in healthcare discussions. "I hope similar inquiries will surface regarding other vaccines and treatments," notes Professor Cooper, who is also studying the potential impacts of hormonal contraceptives on vaccine effectiveness.